We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$169M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$116M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$87.5M
4
ABBV icon
AbbVie
ABBV
+$80.5M
5
JPM icon
JPMorgan Chase
JPM
+$79.3M

Top Sells

Rank Stock Value
1
IGM icon
iShares Expanded Tech Sector ETF
IGM
+$79.2M
2
CMCSA icon
Comcast
CMCSA
+$69.1M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$53.3M
4
META icon
Meta Platforms (Facebook)
META
+$48.1M
5
VZ icon
Verizon
VZ
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WNEB icon
3501
Western New England Bancorp
WNEB
$281M
$173K ﹤0.01%
18,299
-6,000
-25% -$54.7K
CANO
3502
DELISTED
Cano Health, Inc.
CANO
$173K ﹤0.01%
1,260
-54
-4% -$18.3K
CRD.B icon
3503
Crawford & Co Class B
CRD.B
$584M
$172K ﹤0.01%
32,324
+2,642
+9% +$14.7K
TAC icon
3504
TransAlta
TAC
$3.98B
$170K ﹤0.01%
19,000
– –
CGO
3505
Calamos Global Total Return Fund
CGO
$131M
$170K ﹤0.01%
19,228
-900
-4% -$8.29K
BCRX icon
3506
BioCryst Pharmaceuticals
BCRX
$2.52B
$169K ﹤0.01%
+14,734
New +$184K
ACP
3507
abrdn Income Credit Strategies Fund
ACP
$644M
$168K ﹤0.01%
24,735
+636
+3% +$4.24K
SEMR
3508
DELISTED
Semrush
SEMR
$168K ﹤0.01%
20,579
+5,987
+41% +$60.7K
PFD
3509
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
$167K ﹤0.01%
15,005
-2,955
-16% -$32.4K
UPST icon
3510
Upstart Holdings
UPST
$3.01B
$166K ﹤0.01%
12,570
-108,113
-90% -$2.09M
LUNA
3511
DELISTED
Luna Innovations Incorporated
LUNA
$164K ﹤0.01%
18,667
-2,000
-10% -$12.7K
FSLY icon
3512
Fastly Inc
FSLY
$4.77B
$164K ﹤0.01%
20,018
-5,333
-21% -$46.7K
SUZ icon
3513
Suzano
SUZ
$9.85B
$164K ﹤0.01%
+17,720
New +$174K
QS icon
3514
QuantumScape Corp
QS
$3.79B
$163K ﹤0.01%
28,827
-14,889
-34% -$110K
ARHS icon
3515
Arhaus
ARHS
$1.37B
$163K ﹤0.01%
+16,754
New +$146K
NRO
3516
Neuberger Real Estate Securities Income Fund Inc
NRO
$189M
$162K ﹤0.01%
54,271
-12,860
-19% -$41.4K
ETN icon
3517
CALL
Eaton
ETN
$176B
$162K ﹤0.01%
57,100
+11,900
+26% +$1.82M
CEV
3518
Eaton Vance California Municipal Income Trust
CEV
$73.6M
$162K ﹤0.01%
+16,200
New +$157K
KVHI icon
3519
KVH Industries
KVHI
$142M
$160K ﹤0.01%
+15,698
New +$159K
EFC
3520
Ellington Financial
EFC
$1.76B
$160K ﹤0.01%
12,943
+1,851
+17% +$24.1K
HYB
3521
DELISTED
New America High Income Fund, Inc.
HYB
$159K ﹤0.01%
24,105
-1,088
-4% -$7.31K
ARCO icon
3522
Arcos Dorados Holdings
ARCO
$1.71B
$159K ﹤0.01%
19,017
-980
-5% -$7.33K
BNY
3523
DELISTED
BlackRock New York Municipal Income Trust
BNY
$159K ﹤0.01%
15,765
-2,300
-13% -$22.7K
CGC
3524
Canopy Growth
CGC
$426M
$156K ﹤0.01%
6,768
+1,453
+27% +$44.8K
WEA
3525
Western Asset Premier Bond Fund
WEA
$125M
$156K ﹤0.01%
14,672
– –
139 140
141
142 143

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.